Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

XORTX's Research and business update to accelerate growth
Date 06 January 2026

XORTX's Research and business update to accelerate growth

Announcement XORTX Therapeutics Inc., a leading late-stage clinical pharmaceutical company aiming to establish innovative therapies for the treatment of progressive kidney and gout diseases, unveiled...

Cogent enveloped its application to the FDA
Date 05 January 2026

Cogent enveloped its application to the FDA

Announcement Cogent Biosciences, Inc., a leading biotechnology company dedicated to establishing accurate therapies for genetically defined diseases, has now submitted its promising New Drug Applicat...

Tiger BioSciences' recap of 2025's major milestones
Date 05 January 2026

Tiger BioSciences' recap of 2025's major milestones

Recap Tiger BioSciences spotlights the number of important and valuable scientific and clinical advances that have been made from the company’s extensive investment in proof-based research acro...

Autonomix received patent rights from the EPO
Date 05 January 2026

Autonomix received patent rights from the EPO

Announcement Autonomix Medical, Inc., a known medical device company devoted to modernising the accurate nerve-focused treatments, have received an official patent right from the European Patent Offi...

Sinopia's LEADS® Platform is now open to upgrade its potential with the NIGMS stamp
Date 05 January 2026

Sinopia's LEADS® Platform is now open to upgrade its potential with the NIGMS stamp

Announcement Sinopia Biosciences, Inc., a leading biotechnology company known for modernising novel therapeutics with the help of its exclusive LEADS® drug discovery platform, proudly declared th...

Johnson & Johnson obtained Halda's robust platform to equip its potential in business operations
Date 01 January 2026

Johnson & Johnson obtained Halda's robust platform to equip its potential in business operations

Announcement Johnson & Johnson, the popular company, has completed its acquisition of Halda Therapeutics OpCo, Inc., a known clinical-level biotechnology company. Along with this acquisition, Joh...

SELLAS informed of an update of its Phase 3 REGAL trial
Date 01 January 2026

SELLAS informed of an update of its Phase 3 REGAL trial

Announcement SELLAS Life Sciences Group, Inc., a leading late-stage clinical biopharmaceutical company focused on the establishment of novel therapies for a wide range of cancer indications have an u...

Co-Diagnostics received an Australian trademark, with the official introduction to its robust platform and property
Date 01 January 2026

Co-Diagnostics received an Australian trademark, with the official introduction to its robust platform and property

Announcement Co-Diagnostics, Inc., a leading molecular diagnostics company with a remarkable patented platform for the establishment of molecular diagnostics tests, today proudly announced that it ha...

WORK's Hunan to proceed with the manufacturing of a new medical tech-based device
Date 01 January 2026

WORK's Hunan to proceed with the manufacturing of a new medical tech-based device

Announcement WORK Medical Technology Group LTD, a well-known provider of medical devices in China, operates via its branch named Work (Hangzhou) Medical Treatment Equipment Co., Ltd and its other bra...

Caliway cleared one stage of its Phase 2 Clinical Study in Weight Management
Date 31 December 2025

Caliway cleared one stage of its Phase 2 Clinical Study in Weight Management

Announcement Caliway, a leading biopharmaceutical company, proudly announced its submission of an Investigational New Drug (IND) application to the US FDA for its robust Phase 2 clinical study of its...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.